-
-
-
-
-
-
-
Jefferies Downgrades Abivax (ABVX) to Hold
-
-
-
-
-
-
-
Truist on Abivax (ABVX): 'We continue to see a robust opportunity'
-
-
-
-
-
-
-
Guggenheim Reiterates Abivax (ABVX) at Buy, 'ABVX remains as our Best Idea'
-
-
-
-
-
-
-
Abivax secures 22 abstracts on inflammatory bowel disease drug at ECCO 2026
-
-
-
-
-
-
-
Abivax presents ulcerative colitis drug data at gastroenterology meeting
-
-
-
-
-
-
-
Abivax launches $400 million public offering of American depositary shares
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
-
416,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

